These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8794980)

  • 1. The effect of surfactant and solid phase concentration on drug aggregates in model aerosol propellent suspensions.
    Bower C; Washington C; Purewal TS
    J Pharm Pharmacol; 1996 Apr; 48(4):342-6. PubMed ID: 8794980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of surfactant effect on aggregates in model aerosol propellent suspensions.
    Bower C; Washington C; Purewal TS
    J Pharm Pharmacol; 1996 Apr; 48(4):337-41. PubMed ID: 8794979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheology of model aerosol suspensions.
    Sidhu BK; Washington C; Davis SS; Purewal TS
    J Pharm Pharmacol; 1993 Jul; 45(7):597-600. PubMed ID: 8105051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
    Zeng XM; Martin GP; Marriott C; Pritchard J
    J Pharm Pharmacol; 2000 Oct; 52(10):1211-21. PubMed ID: 11092565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microcalorimetric investigation of the interaction of surfactants with crystalline and partially crystalline salbutamol sulphate in a model inhalation aerosol system.
    Blackett PM; Buckton G
    Pharm Res; 1995 Nov; 12(11):1689-93. PubMed ID: 8592671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP; Marriott C; Zeng XM
    Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution and adsorption behaviour of lecithin surfactants in CFC suspensions: a light scattering study in aerosol propellants.
    Malik S; Washington C; Purewal TS
    Int J Pharm; 1999 Sep; 186(1):63-9. PubMed ID: 10469924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers.
    Phillips EM; Byron PR; Dalby RN
    Pharm Res; 1993 Mar; 10(3):454-6. PubMed ID: 8464823
    [No Abstract]   [Full Text] [Related]  

  • 10. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
    Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
    Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S; Young PM; Traini D
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of various surfactants on the release of salbutamol from suppositories.
    Hanaee J; Javadzadeh Y; Taftachi S; Farid D; Nokhodchi A
    Farmaco; 2004 Nov; 59(11):903-6. PubMed ID: 15544795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of heliox on nebulizer function using a beta-agonist bronchodilator.
    Hess DR; Acosta FL; Ritz RH; Kacmarek RM; Camargo CA
    Chest; 1999 Jan; 115(1):184-9. PubMed ID: 9925082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Murnane D; Martin GP; Marriott C
    J Pharm Sci; 2009 Feb; 98(2):503-15. PubMed ID: 18506819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring nebulizer output. Aerosol production vs gravimetric analysis.
    Tandon R; McPeck M; Smaldone GC
    Chest; 1997 May; 111(5):1361-5. PubMed ID: 9149595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oil type on the aggregation stability of nanostructured lipid carriers.
    Yang Y; Corona A; Schubert B; Reeder R; Henson MA
    J Colloid Interface Sci; 2014 Mar; 418():261-72. PubMed ID: 24461844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate.
    Heng PW; Chan LW; Lim LT
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):393-8. PubMed ID: 10726864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscosity behavior of silica suspensions flocculated by associating polymers.
    Kamibayashi M; Ogura H; Otsubo Y
    J Colloid Interface Sci; 2005 Oct; 290(2):592-7. PubMed ID: 15939431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for the production of crystalline micronised particles.
    Muhammad SA; Langrish T; Tang P; Adi H; Chan HK; Kazarian SG; Dehghani F
    Int J Pharm; 2010 Mar; 388(1-2):114-22. PubMed ID: 20043982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of the aqueous suspensions of nanotubes in the presence of nonionic surfactant.
    Lisunova MO; Lebovka NI; Melezhyk OV; Boiko YP
    J Colloid Interface Sci; 2006 Jul; 299(2):740-6. PubMed ID: 16600279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.